Canada’s Life Sciences Can’t Wait | Ottawa News
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
Canada’s life sciences sector is in urgent need of action—experts warn that without swift follow-through on promised billion-dollar funding and streamlined drug testing processes, the country risks falling behind globally. With the Venture and Growth Capital Catalyst Initiative still untouched, advocates like Wendy Zatylny from BIOTECanada are sounding the alarm. Health Minister Marjorie Michel pledged to review Task Force recommendations to boost affordability and industry strength—but real progress hinges on decisive government moves now.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Sources:
https://www.hilltimes.com/2026/09/16/canada-losing-ground-in-global-life-sciences-race-needs-quicker-funding-and-harmonized-clinical-trials-system-say-sector-experts/518041/
More coverage & latest updates:
https://sources.thednn.ai/e68d1207fbd8dfc4
Report issues to feedback@thednn.ai.